Rockwell Medical (RMTI) Profit After Tax Growth (3y) (2013 - 2026)
Rockwell Medical (RMTI) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 14.01% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 2.89% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 15.37% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn | 29.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.22% |
| Mar 31, 2026 | 2.84% |
| Dec 31, 2025 | 38.33% |
| Sep 30, 2025 | 25.21% |
| Jun 30, 2025 | 33.03% |
| Mar 31, 2025 | 40.42% |
| Dec 31, 2024 | 56.11% |
| Sep 30, 2024 | 30.44% |
| Jun 30, 2024 | 26.84% |
| Mar 31, 2024 | 39.33% |
| Dec 31, 2023 | 44.12% |
| Sep 30, 2023 | 36.61% |
| Jun 30, 2023 | 21.73% |
| Mar 31, 2023 | 39.71% |
| Dec 31, 2022 | 31.35% |
| Sep 30, 2022 | 18.90% |
| Jun 30, 2022 | 21.56% |
| Mar 31, 2022 | 6.20% |
| Dec 31, 2021 | 1.57% |
| Sep 30, 2021 | -15.12% |